More than 2,300 psilocybin users report real-world outcomes in Oregon and Colorado

Over the past few decades, some psychiatrists and medical researchers have been running controlled clinical trials to assess the potential therapeutic value of psychedelics, substances that alter perception, mood and thinking patterns. One of the most widely studied is psilocybin, a compound found in some species of mushrooms.